These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

547 related items for PubMed ID: 19444865

  • 1. Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload.
    Lecube A, Hernández C, Simó R.
    Diabetes Metab Res Rev; 2009 Jul; 25(5):403-10. PubMed ID: 19444865
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G, Vario A, Ferrari A, Pistis R, Noventa F, Alberti A.
    J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
    [Abstract] [Full Text] [Related]

  • 6. Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet.
    Kato J, Kobune M, Nakamura T, Kuroiwa G, Takada K, Takimoto R, Sato Y, Fujikawa K, Takahashi M, Takayama T, Ikeda T, Niitsu Y.
    Cancer Res; 2001 Dec 15; 61(24):8697-702. PubMed ID: 11751387
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of iron status in patients with chronic hepatitis C.
    Sartori M, Andorno S, La Terra G, Boldorini R, Leone F, Pittau S, Zecchina G, Aglietta M, Saglio G.
    Ital J Gastroenterol Hepatol; 1998 Aug 15; 30(4):396-401. PubMed ID: 9789136
    [Abstract] [Full Text] [Related]

  • 8. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
    Fujita N, Horiike S, Sugimoto R, Tanaka H, Iwasa M, Kobayashi Y, Hasegawa K, Ma N, Kawanishi S, Adachi Y, Kaito M.
    Free Radic Biol Med; 2007 Feb 01; 42(3):353-62. PubMed ID: 17210448
    [Abstract] [Full Text] [Related]

  • 9. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S, Younossi ZM.
    Minerva Gastroenterol Dietol; 2006 Jun 01; 52(2):135-43. PubMed ID: 16557185
    [Abstract] [Full Text] [Related]

  • 10. Iron overload and glucose abnormalities in chronic hepatitis C virus infection: phlebotomy lowers risk of new-onset diabetes.
    Mifuji-Moroka R, Iwasa M, Miyachi H, Sugimoto R, Tanaka H, Ishihara T, Fujita N, Kaito M, Kobayashi Y, Takei Y.
    Hepatogastroenterology; 2013 Oct 01; 60(127):1736-41. PubMed ID: 24634944
    [Abstract] [Full Text] [Related]

  • 11. Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C.
    Di Marco V, Capra M, Gagliardotto F, Borsellino Z, Cabibi D, Barbaria F, Ferraro D, Cuccia L, Ruffo GB, Bronte F, Di Stefano R, Almasio PL, Craxì A.
    Haematologica; 2008 Aug 01; 93(8):1243-6. PubMed ID: 18556410
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N, Younossi ZM.
    Expert Rev Gastroenterol Hepatol; 2008 Apr 01; 2(2):207-15. PubMed ID: 19072356
    [Abstract] [Full Text] [Related]

  • 14. [Hepatitis C virus-associated and metabolic steatosis. Different or overlapping diseases?].
    Lonardo A, Loria P, Adinolfi LE, Andreana A, Ruggiero G, Carulli N.
    Ann Ital Med Int; 2005 Apr 01; 20(1):10-22. PubMed ID: 15859390
    [Abstract] [Full Text] [Related]

  • 15. Synergic effect of chronic hepatitis C infection and beta thalassemia major with marked hepatic iron overload on liver fibrosis: a retrospective cross-sectional study.
    Ardalan FA, Osquei MR, Toosi MN, Irvanloo G.
    BMC Gastroenterol; 2004 Aug 12; 4():17. PubMed ID: 15307893
    [Abstract] [Full Text] [Related]

  • 16. Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C virus infection and non-alcoholic fatty liver disease.
    Vecchiet J, Falasca K, Cacciatore P, Zingariello P, Dalessandro M, Marinopiccoli M, D'Amico E, Palazzi C, Petrarca C, Conti P, Pizzigallo E, Guagnano MT.
    Ann Clin Lab Sci; 2005 Aug 12; 35(4):415-22. PubMed ID: 16254258
    [Abstract] [Full Text] [Related]

  • 17. [Changes in iron metabolism in chronic hepatitis C].
    Fernández Salazar L, García Buey L, Moreno Otero R.
    Rev Esp Enferm Dig; 1999 Aug 12; 91(8):583-9. PubMed ID: 10491490
    [Abstract] [Full Text] [Related]

  • 18. Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload.
    Brudevold R, Hole T, Hammerstrøm J.
    PLoS One; 2008 Aug 12; 3(10):e3547. PubMed ID: 18958176
    [Abstract] [Full Text] [Related]

  • 19. Role of iron in the natural history and clinical course of hepatitis C disease.
    Shedlofsky SI.
    Hepatogastroenterology; 1998 Aug 12; 45(20):349-55. PubMed ID: 9638405
    [Abstract] [Full Text] [Related]

  • 20. Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage.
    Valenti L, Dongiovanni P, Piperno A, Fracanzani AL, Maggioni M, Rametta R, Loria P, Casiraghi MA, Suigo E, Ceriani R, Remondini E, Trombini P, Fargion S.
    Hepatology; 2006 Oct 12; 44(4):857-64. PubMed ID: 17006922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.